Brief: Anthera Receives Positive Nasdaq Listing Determination
25/01/2018 21:30
Jan 25 (Reuters) - Anthera Pharmaceuticals Inc ANTH.O :
* ANTHERA RECEIVES POSITIVE NASDAQ LISTING DETERMINATION
Source text for Eikon: ID:nGNXOMQHHa
Further company coverage: ANTH.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Anthera Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Micron, Darden, Kroger, American Outdoor
Brief: Anthera Pharma's Board Approves Personnel Reorganization Plan
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Netflix, BlueLinx, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, BlueLinx, Orexigen, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Orexigen, Goldman